Sulfonamide-induced bullous hemorrhagic eruption in a patient with low prothrombin time.
Wolf
R
R
Department of Dermatology, Tel Aviv Medical Center, Ichilov, Israel.
Elman
M
M
Brenner
S
S
D001706:Biopsy; D003875:Drug Eruptions / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D004347:Drug Interactions; D004804:Eosinophils / Q000473:pathology; D004917:Erythromycin / Q000009:adverse effects*; D005260:Female; D005448:Fluocortolone / Q000008:administration & dosage / Q000627:therapeutic use; D006406:Hematoma / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000473:pathology; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D009504:Neutrophils / Q000473:pathology; D011517:Prothrombin Time; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*; D014859:Warfarin / Q000009:adverse effects*
D014859:Warfarin; D004917:Erythromycin; D005448:Fluocortolone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination